Search

everythinglearnresearchcommunity

for

Search:↓

A new method using Y-27632 improves the growth and quality of human hair follicle stem cells for tissue engineering and therapy.

Regulatory T cells help hair growth by using the Cxcr4-Cxcl12 pathway.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Lef1 helps adult skin cells maintain their ability to heal wounds and regenerate hair, but the study's methods and conclusions have been questioned.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

Foxc1 helps keep hair follicle stem cells inactive, preventing hair loss.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

The scaffold helps wounds heal without scars and promotes hair growth.

Peficitinib can turn human fibroblasts into cells that help grow hair.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Topical tacrolimus reduces certain growth factors in hair follicles.

Decreased IGF-1R expression may contribute to sacrococcygeal pilonidal sinus development.

Surgical excision is the best treatment for SCC.

TGF-β1 and TNF-α contribute to lung damage after radiation.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Tofacitinib may help regrow hair in alopecia areata patients.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Targeting regulatory T cells may help treat age-related diseases.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

CD34⁺ cells help heal damaged limbs by promoting blood vessel growth.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.